This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Terttu Lamminen: Innovator in Veterinary Pharmaceuticals
Introduction
Terttu Lamminen is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of veterinary medicine, particularly in the development of pharmaceutical compositions for companion animals.
Latest Patents
Lamminen holds a patent for "Pregabalin formulations and use thereof." This invention relates to a pharmaceutical composition in the form of an orally deliverable liquid that comprises pregabalin as an active ingredient. The composition is designed for the treatment and prevention of transportation and veterinary visit anxiety and fear in companion animals, such as cats. It is characterized by its stability, palatability for animals, and ease of administration by pet owners.
Career Highlights
Terttu Lamminen is associated with Orion Corporation, a leading company in the pharmaceutical industry. His work focuses on improving the well-being of animals through innovative medical solutions.
Collaborations
Lamminen has collaborated with notable colleagues, including Jurgen Vercruysse and Johanna Tervapuro, who contribute to the advancement of veterinary pharmaceuticals.
Conclusion
Terttu Lamminen's work in developing effective pharmaceutical solutions for companion animals highlights his commitment to enhancing animal health and welfare. His innovative approach continues to make a positive impact in the veterinary field.